Acurx Pharmaceuticals, Inc.盘中异动早盘大幅上涨5.45%报0.870美元

市场透视12-17

北京时间2024年12月17日22时41分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.45%。截至发稿，该股报0.870美元/股，成交量2.2041万股，换手率0.13%，振幅4.81%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.82百万美元，每股收益-0.17美元，毛利0.00美元，市盈率-0.79倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492896539?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-17 22:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492896539","market":"us","top_or_hot":-1,"title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.45%报0.870美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月17日22时41分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.45%。截至发稿，该股报0.870美元/股，成交量2.2041万股，换手率0.13%，振幅4.81%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.82百万美元，每股收益-0.17美元，毛利0.00美元，市盈率-0.79倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224156984c9081&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acurx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.45%报0.870美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcurx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.45%报0.870美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 22:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224156984c9081&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月17日22时41分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.45%。截至发稿，该股报0.870美元/股，成交量2.2041万股，换手率0.13%，振幅4.81%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.82百万美元，每股收益-0.17美元，毛利0.00美元，市盈率-0.79倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224156984c9081&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACXP","symbol_name":"Acurx Pharmaceuticals, LLC*","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224156984c9081&s=b","article_id":"2492896539","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224156984c9081&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492896539","pubTimestamp":1734446516,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月17日22时41分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.45%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ACXP":"Acurx Pharmaceuticals, LLC*","BK4539":"次新股","BK4139":"生物科技","BK4563":"昨日强势股"},"translate_title":"Acurx Pharmaceuticals, Inc. surged 5.45% to $0.870 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACXP":0.9},"content_text":"北京时间2024年12月17日22时41分，Acurx Pharmaceuticals, Inc.（ACXP.us）股票出现异动，股价大幅拉升5.45%。截至发稿，该股报0.870美元/股，成交量2.2041万股，换手率0.13%，振幅4.81%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.82百万美元，每股收益-0.17美元，毛利0.00美元，市盈率-0.79倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Jupiter Neurosciences, Inc.涨幅较大，Portage Biotech Inc.、Polyrizon Ltd.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1477.56%、88.97%、17.88%，振幅较大的相关个股有Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025(To Pur Com)、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)，振幅分别为46.46%、23.99%、21.57%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492896539"}

Acurx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.45%报0.870美元

精彩评论

Acurx Pharmaceuticals, Inc.盘中异动早盘大幅上涨5.45%报0.870美元